We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
-14.12%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$64.1B
AUM Growth
-$17.5B
Cap. Flow
-$4.25B
Cap. Flow %
-6.62%
Top 10 Hldgs %
6.66%
Holding
4,541
New
702
Increased
1,343
Reduced
1,571
Closed
844

Top Sells

Rank Stock Value
1
FTV icon
Fortive
FTV
+$1.27B
2
ANDV
Andeavor
ANDV
+$1.11B
3
AET
Aetna Inc
AET
+$535M
4
MSFT icon
Microsoft
MSFT
+$350M
5
AMZN icon
Amazon
AMZN
+$290M

Sector Composition

Rank Sector Weight
1 Healthcare 13.69%
2 Technology 13.64%
3 Financials 12.49%
4 Consumer Discretionary 10.83%
5 Industrials 9.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COHU icon
3776
Cohu
COHU
$2.57B
-335,308
Closed -$8.42M
COR icon
3777
CALL
Cencora
COR
$60.7B
-86,000
Closed -$7.93M
COR icon
3778
PUT
Cencora
COR
$60.7B
-50,000
Closed -$4.61M
CPB icon
3779
CALL
Campbell Soup
CPB
$7.14B
-15,000
Closed -$549K
CPRX
3780
DELISTED
Catalyst Pharmaceutical
CPRX
-134,019
Closed -$507K
CRD.B icon
3781
Crawford & Co Class B
CRD.B
$583M
-14,400
Closed -$133K
CRF
3782
Cornerstone Total Return Fund
CRF
$1.12B
-26,001
Closed -$354K
CRON
3783
PUT
Cronos Group
CRON
$1.22B
-200,000
Closed -$2.22M
CRSP icon
3784
CRISPR Therapeutics
CRSP
$5.75B
-67,179
Closed -$2.98M
CRVO icon
3785
CervoMed
CRVO
$39.6M
-205
Closed -$100K
CSR
3786
Centerspace
CSR
$906M
-27,472
Closed -$1.64M
CTLP
3787
CALL
DELISTED
Cantaloupe
CTLP
-320,400
Closed -$2.31M
CUK
3788
DELISTED
Carnival PLC
CUK
-3,351
Closed -$211K
CVBF icon
3789
CVB Financial
CVBF
$3.97B
-31,939
Closed -$713K
CVGW
3790
DELISTED
Calavo Growers
CVGW
-3,789
Closed -$366K
CWEN icon
3791
Clearway Energy Class C
CWEN
$6.68B
-93,384
Closed -$1.8M
DB icon
3792
CALL
Deutsche Bank
DB
$71.1B
-300,000
Closed -$3.41M
DE icon
3793
CALL
Deere & Co
DE
$175B
-75,000
Closed -$11.3M
DEA
3794
Easterly Government Properties
DEA
$1.16B
-248,710
Closed -$12M
DFP
3795
Flaherty & Crumrine Dynamic Preferred and Income Fund
DFP
$426M
-8,957
Closed -$208K
DGICA icon
3796
Donegal Group Class A
DGICA
$693M
-22,730
Closed -$323K
DGX icon
3797
Quest Diagnostics
DGX
$27B
-181,597
Closed -$19.6M
DGX icon
3798
PUT
Quest Diagnostics
DGX
$27B
-120,000
Closed -$12.9M
DHT icon
3799
DHT Holdings
DHT
$3.2B
-13,779
Closed -$65K
DLNG icon
3800
Dynagas LNG Partners
DLNG
$141M
-12,576
Closed -$110K

Similar funds

Israel Englander's Q4 2018 Portfolio in Review

As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.

Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.

  • Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
  • Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
  • Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
  • Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
  • Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
  • Israel Englander opened 702 new positions and closed 844 in Q4 2018.
  • Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.

Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.